Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26392,125,1.36 [0.94-1.96],0.1007564708745747
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27129,203,0.96 [0.69-1.33],0.799168505822226
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26850,1344,1.12 [0.99-1.26],0.071359360658416
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Candidiasis,27156,466,0.86 [0.68-1.07],0.1780937167317345
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26304,3478,0.99 [0.92-1.08],0.8626691473398623
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26541,2868,1.06 [0.97-1.15],0.2179446753195668
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,26870,1362,0.98 [0.86-1.11],0.7041093965527214
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27050,91,1.21 [0.77-1.90],0.4076401603801171
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25310,807,1.06 [0.91-1.25],0.4494879568034238
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24484,954,1.23 [1.07-1.42],0.003502498830867
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,24502,255,1.11 [0.84-1.48],0.4488944157970745
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19062,1663,1.09 [0.98-1.22],0.1159792297417322
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24273,374,1.13 [0.90-1.43],0.2986885442653516
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27096,1588,0.97 [0.86-1.09],0.6400990906168682
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Mycoses,27218,528,0.93 [0.76-1.15],0.5197340878785643
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26462,956,1.15 [1.00-1.33],0.051107903849619
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27162,895,1.11 [0.95-1.29],0.1908677472252431
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25711,203,0.95 [0.69-1.33],0.7794011624012398
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27280,46,1.23 [0.65-2.32],0.529813346713545
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27048,781,1.10 [0.94-1.29],0.2502265069774156
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27039,80,0.72 [0.41-1.25],0.2366835327392753
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27180,191,1.06 [0.76-1.48],0.7168932294790027
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27163,174,1.00 [0.70-1.42],0.9959391966442604
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25854,348,1.04 [0.81-1.33],0.7526852985703278
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,25771,265,0.92 [0.69-1.23],0.5804108294875044
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,25636,128,1.24 [0.84-1.82],0.270494253274974
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27257,36,0.56 [0.23-1.32],0.1829337631198113
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27203,159,1.00 [0.69-1.45],0.992040222819404
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Viral warts,27090,46,0.81 [0.39-1.66],0.5593649176458438
CEBPB,CCAAT/enhancer-binding protein beta,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27122,78,1.01 [0.59-1.71],0.9825935879508036
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm,27009,244,0.77 [0.56-1.06],0.1059282927472861
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27177,71,1.02 [0.59-1.77],0.9328654729632672
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27173,70,0.94 [0.53-1.65],0.8200821066792463
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27003,1205,0.84 [0.73-0.96],0.0127076936146584
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of meninges,27252,81,1.13 [0.69-1.84],0.6309728243133603
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27210,65,1.06 [0.60-1.88],0.8493126162170459
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27246,136,0.89 [0.59-1.35],0.5949397091637394
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm of ovary,27196,177,0.75 [0.52-1.09],0.1334868202078386
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27260,274,0.76 [0.56-1.02],0.0690323434784663
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Caecum,27266,247,0.85 [0.63-1.16],0.3155903507766044
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27195,61,0.80 [0.43-1.51],0.4916602296706533
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Descending colon,27262,155,0.78 [0.53-1.16],0.2223270474894507
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Rectum,27226,277,0.72 [0.53-0.97],0.0327374029734909
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27180,487,0.89 [0.72-1.10],0.2889640829095531
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27260,288,0.79 [0.59-1.05],0.1045026529107216
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Carcinoma in situ of breast,22115,137,0.96 [0.64-1.43],0.8373342020037239
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22202,165,0.90 [0.62-1.30],0.5690746225828872
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22185,33,0.38 [0.15-0.95],0.0377990436651083
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22218,66,1.16 [0.67-2.02],0.5943639092861095
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27211,138,0.76 [0.50-1.17],0.2115074730623418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Haemangioma, any site",27212,136,0.78 [0.51-1.20],0.2569216144768005
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Leiomyoma of uterus,26286,584,0.90 [0.74-1.09],0.2732442781699904
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Lung cancer and mesothelioma,19553,309,1.09 [0.84-1.42],0.526014661023749
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Lymphoid leukaemia,22190,38,0.65 [0.29-1.50],0.3151681699868368
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22327,175,0.71 [0.49-1.05],0.0837960489317024
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22266,114,0.90 [0.58-1.42],0.6575316225891199
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22335,183,1.07 [0.77-1.51],0.6770280011573759
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22222,70,0.96 [0.55-1.69],0.8893456025529507
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22221,69,0.89 [0.50-1.59],0.6974387070495836
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22209,57,0.81 [0.42-1.54],0.514255835547194
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22289,137,0.94 [0.63-1.41],0.7772953101267458
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22257,105,1.37 [0.93-2.04],0.1149871612210101
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22236,84,1.31 [0.84-2.05],0.2374000463237005
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22195,43,0.89 [0.42-1.86],0.7570284201142307
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22232,80,1.10 [0.66-1.83],0.7067496617859229
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi,27015,227,0.96 [0.70-1.31],0.7838400447976182
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanocytic naevi of trunk,27233,80,1.29 [0.81-2.05],0.2849768256473788
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Melanoma in situ,22187,88,0.90 [0.54-1.51],0.6893627390954306
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22233,81,1.02 [0.60-1.71],0.9481233201839288
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22305,153,1.09 [0.76-1.57],0.6422553299606366
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22378,226,0.84 [0.61-1.16],0.2805660935754367
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22249,97,1.28 [0.84-1.96],0.2468193768631859
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,Other benign neoplasms of skin,27052,170,0.79 [0.54-1.16],0.2326090428291757
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23089,937,0.91 [0.78-1.07],0.2568471888296795
CEBPB,CCAAT/enhancer-binding protein beta,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23128,976,0.90 [0.77-1.05],0.1822922274671548
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26979,370,1.05 [0.82-1.33],0.7142009254170623
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25268,106,1.47 [1.00-2.16],0.0527615911246606
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,26675,66,1.17 [0.68-2.02],0.5638416744836302
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26263,2952,0.96 [0.88-1.05],0.341608991550593
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,25637,33,0.39 [0.16-0.98],0.0457972985554138
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,26880,45,1.12 [0.57-2.18],0.749497895749442
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26698,1536,0.95 [0.84-1.07],0.4306237734318681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26698,1536,0.95 [0.84-1.07],0.4306237734318681
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25231,69,0.91 [0.51-1.62],0.7533189633823935
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26873,1269,1.00 [0.88-1.14],0.9932749441484936
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,26952,117,0.77 [0.49-1.21],0.2571440834223951
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,26662,53,0.77 [0.39-1.50],0.4378026167460634
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,26665,56,0.55 [0.28-1.11],0.0960195166509546
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27067,232,1.16 [0.87-1.55],0.3086433607986695
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27164,61,1.52 [0.93-2.47],0.0938201375632303
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27032,197,1.08 [0.78-1.49],0.6306939807022369
CEBPB,CCAAT/enhancer-binding protein beta,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,25737,133,0.88 [0.58-1.33],0.535441864928086
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21965,252,1.14 [0.87-1.50],0.3509358322902467
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25855,65,1.14 [0.65-1.99],0.6412432409358857
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25851,61,1.03 [0.57-1.86],0.9276454397086806
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,21764,51,1.54 [0.91-2.61],0.1074432987707312
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25007,72,0.98 [0.56-1.70],0.9326381629723016
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,24648,247,0.80 [0.59-1.09],0.1630485044467532
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",26838,510,1.00 [0.81-1.23],0.9858052445712128
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,26616,288,1.08 [0.82-1.42],0.5900502534141665
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,26417,89,0.97 [0.59-1.61],0.9153994224371418
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,26879,1944,0.97 [0.87-1.07],0.523935622751905
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24125,1894,0.97 [0.87-1.08],0.5807126431091798
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",21769,56,0.93 [0.49-1.74],0.8093897213236049
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24192,118,1.05 [0.69-1.59],0.8323115612468629
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21996,283,1.10 [0.85-1.44],0.4632802947100963
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,21758,45,1.31 [0.71-2.42],0.3954499803275344
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24829,3116,0.99 [0.91-1.07],0.7650110533285632
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21911,198,1.03 [0.74-1.43],0.8572074356549163
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22242,529,1.14 [0.94-1.38],0.1799128768131671
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27173,368,0.98 [0.76-1.25],0.8505912919685022
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,26989,184,0.93 [0.65-1.32],0.6848663183187027
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,21810,97,1.13 [0.72-1.77],0.6034575186415417
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",21768,55,0.99 [0.53-1.85],0.9807149483496588
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26392,2318,0.89 [0.80-0.98],0.0209258692059433
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21918,205,1.11 [0.81-1.52],0.5201149494710213
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21923,210,1.10 [0.80-1.50],0.5558231100834448
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22242,529,0.94 [0.77-1.15],0.5577746953216749
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,21802,89,1.09 [0.67-1.76],0.7266144044733636
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,26979,174,1.01 [0.71-1.44],0.9447890172311584
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22334,621,0.90 [0.74-1.09],0.2905129697422501
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22273,560,0.90 [0.73-1.10],0.2886479091845315
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,24471,70,0.80 [0.45-1.44],0.465933785629317
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26368,4655,0.99 [0.93-1.06],0.8110639828361491
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24150,76,0.79 [0.45-1.39],0.4193847149983274
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24165,91,0.89 [0.54-1.47],0.6466577735065883
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27078,2079,0.88 [0.79-0.97],0.0136614881965594
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27084,2079,0.88 [0.79-0.97],0.0149137845326355
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24155,81,0.64 [0.36-1.13],0.1220342130686466
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,26875,1596,0.97 [0.86-1.09],0.6253469063391803
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23221,1508,0.99 [0.88-1.12],0.9257840757474324
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27265,183,0.95 [0.67-1.35],0.7663023488196403
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,26386,58,1.51 [0.90-2.54],0.1172381908750125
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,25410,131,0.98 [0.65-1.47],0.9052178228155008
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,25475,196,0.96 [0.69-1.35],0.8252815027240124
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21984,271,1.01 [0.76-1.34],0.9365452183989782
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25451,140,1.15 [0.78-1.67],0.4807244897062376
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1701,48,0.41 [0.19-0.86],0.0177263228486038
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1814,185,0.81 [0.56-1.16],0.2472022873105869
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25337,26,1.23 [0.51-2.96],0.6505365576550725
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1685,33,0.84 [0.36-1.95],0.6805375467026973
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26793,1482,1.23 [1.10-1.37],0.0003866418716629
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,26668,340,1.12 [0.88-1.44],0.3554070251606367
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,24886,485,0.81 [0.65-1.01],0.0609656760508144
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22441,728,0.91 [0.76-1.08],0.2904535212126536
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27179,229,0.98 [0.71-1.33],0.8770663937923879
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26270,54,1.27 [0.72-2.24],0.4141902665297559
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Angina pectoris,25749,871,1.03 [0.88-1.21],0.6939219251043696
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26313,97,0.83 [0.51-1.36],0.4546612411829597
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26250,34,1.29 [0.64-2.61],0.4747113287185418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26363,147,1.12 [0.77-1.62],0.5580185580106677
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17746,1470,1.13 [1.01-1.27],0.0363117512428682
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,AV-block,23893,242,1.01 [0.75-1.37],0.939425306781006
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27239,306,0.94 [0.72-1.24],0.6806866332558017
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiac arrest,16402,126,1.09 [0.73-1.62],0.6878657385215092
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23784,133,0.79 [0.51-1.21],0.276809873641096
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",23729,78,1.00 [0.59-1.70],0.9930641792532718
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27276,34,0.57 [0.24-1.39],0.2195493945394605
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Conduction disorders,24374,723,1.06 [0.90-1.26],0.4731057001534055
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26362,1496,1.15 [1.02-1.29],0.0218649991554619
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24514,7208,1.02 [0.97-1.08],0.3830871622339479
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25775,244,0.95 [0.70-1.28],0.7259151926763268
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Endocarditis,23710,59,1.03 [0.56-1.89],0.9155926657193708
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27183,856,1.28 [1.10-1.48],0.0010791348368893
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertension,25131,6091,1.05 [0.99-1.12],0.0941560037667556
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25144,6104,1.05 [0.99-1.12],0.0963528031923161
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27169,43,0.57 [0.26-1.24],0.1548866787911562
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19202,162,1.34 [0.97-1.85],0.077294408137747
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19147,107,1.30 [0.86-1.97],0.2207794570433821
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Hypotension,27140,1103,1.02 [0.89-1.17],0.7728649421797054
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,26525,93,0.88 [0.53-1.46],0.6163978279384146
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26561,1683,1.11 [1.00-1.24],0.0610596250921435
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26962,449,1.09 [0.88-1.36],0.4160258344170829
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Left bundle-branch block,23949,298,1.23 [0.96-1.59],0.1030021520926194
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27056,602,1.04 [0.86-1.26],0.669086377584055
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25362,484,0.97 [0.78-1.20],0.7571207418267375
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27253,87,0.84 [0.50-1.42],0.5135221684889532
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27271,241,0.75 [0.54-1.03],0.0760074993360398
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Oesophageal varices,25567,36,0.69 [0.30-1.59],0.3806169153305062
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other aneurysm,26273,57,1.30 [0.75-2.24],0.3488907587829916
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arrhythmias,24005,354,1.02 [0.80-1.31],0.8581672702974483
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26280,64,1.33 [0.79-2.22],0.2856989870464664
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26404,188,1.18 [0.85-1.62],0.3244532589352282
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,23807,156,1.35 [0.98-1.87],0.0665155743011854
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other disorders of veins,25629,98,0.86 [0.53-1.40],0.5425138973667825
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,25578,47,1.26 [0.68-2.35],0.4653821503441141
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26028,40,0.83 [0.38-1.80],0.6428870353408833
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,25693,162,1.13 [0.80-1.61],0.4852876818296698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24453,802,1.02 [0.87-1.21],0.7982352054428133
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26081,44,0.66 [0.31-1.42],0.2879713109205089
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26719,503,0.89 [0.72-1.11],0.3072525642430155
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26695,318,1.21 [0.94-1.54],0.1320186694746801
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",26539,551,1.02 [0.83-1.24],0.8708176863024923
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16565,289,0.99 [0.76-1.31],0.9651593076714288
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26476,273,1.01 [0.76-1.33],0.9609646598810784
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25850,319,0.88 [0.67-1.16],0.3641034048221517
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26828,451,1.15 [0.93-1.41],0.2059848480720348
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27204,587,1.01 [0.83-1.23],0.9074024256892016
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Right bundle-branch block,23869,218,1.00 [0.73-1.38],0.9947579591485622
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26686,309,1.26 [0.99-1.61],0.06052679455786
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26149,161,0.98 [0.68-1.42],0.9109952025556134
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26955,523,1.05 [0.86-1.29],0.6220399183763963
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26929,570,1.04 [0.86-1.27],0.6688190667033151
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,26492,70,0.97 [0.56-1.70],0.926769692668862
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26263,47,1.00 [0.51-1.96],0.995554753482758
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26729,216,0.94 [0.68-1.30],0.6952878423061929
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26652,198,1.14 [0.83-1.57],0.4190548254190869
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Varicose veins,25995,464,0.90 [0.72-1.13],0.3717419148213815
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26227,94,0.88 [0.54-1.45],0.6241748418946576
CEBPB,CCAAT/enhancer-binding protein beta,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27065,706,1.05 [0.88-1.25],0.5644842891856763
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27236,216,0.79 [0.57-1.10],0.1671450591671375
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24220,1857,0.97 [0.87-1.08],0.6245498380467887
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Any mental disorder,26669,4306,1.00 [0.93-1.07],0.917866891520126
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27204,254,0.99 [0.74-1.32],0.922512692992253
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24328,1965,0.98 [0.88-1.09],0.7124825081899497
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22457,94,1.08 [0.67-1.74],0.7425103805721689
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Smoking dependency,26869,1197,0.98 [0.86-1.12],0.7962114143964245
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23739,1376,0.97 [0.85-1.09],0.5848512811023632
CEBPB,CCAAT/enhancer-binding protein beta,Chapter V Mental and behavioural disorders,Vascular dementia,26773,100,1.15 [0.73-1.81],0.5515610369918605
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Alzheimer disease,27280,358,1.01 [0.79-1.30],0.9188725209925844
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",18617,59,0.89 [0.47-1.67],0.7091144477443337
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Bell's palsy,25125,83,0.59 [0.34-1.03],0.0656920106474967
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25670,628,0.94 [0.78-1.13],0.5118075340566854
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral cysts,26877,222,0.93 [0.67-1.27],0.6395324511289072
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27206,276,0.86 [0.64-1.15],0.3023814495460122
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,26790,40,1.37 [0.72-2.60],0.3309217022865628
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27266,47,0.95 [0.48-1.89],0.8823106125585484
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",26712,57,1.32 [0.76-2.28],0.3186700124080307
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Epilepsy,25810,280,0.79 [0.59-1.06],0.1231337561351419
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26863,1333,0.91 [0.80-1.03],0.1402016272370516
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27232,510,0.99 [0.81-1.23],0.9620314695331472
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26641,2902,1.00 [0.92-1.09],0.9398472381878092
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Generalized epilepsy,26911,46,0.83 [0.40-1.71],0.6196109015602178
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hemiplegia,27148,218,0.96 [0.69-1.32],0.7839148073572924
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Hydrocephalus,26722,67,1.13 [0.65-1.96],0.6618567012858849
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27259,79,0.92 [0.53-1.57],0.7502612077126146
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25167,125,0.71 [0.46-1.12],0.1412387912178395
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25104,62,1.03 [0.58-1.85],0.9121868578187952
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Memory loss,26647,95,1.11 [0.70-1.77],0.6575874715110335
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Migraine,26029,499,0.89 [0.72-1.11],0.3050477196658867
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27165,447,0.81 [0.64-1.02],0.0796949363232258
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Motor neuron disease,18704,121,1.06 [0.70-1.61],0.7889303654547825
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27064,144,0.88 [0.59-1.31],0.5262625522067433
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26427,1385,0.96 [0.85-1.09],0.5248119209822079
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Neurological diseases,25667,3791,0.95 [0.88-1.02],0.1700820064927592
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,26911,161,0.68 [0.45-1.01],0.0579279441291059
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25466,424,1.10 [0.88-1.37],0.3897721654061872
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27222,235,1.05 [0.77-1.41],0.7726463600104914
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21968,668,0.91 [0.75-1.10],0.3210179654117474
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,26720,65,1.32 [0.79-2.20],0.2906575763486267
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other disorders of nervous system,26777,122,0.95 [0.62-1.46],0.8052863156852009
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,26904,182,0.95 [0.67-1.35],0.7715987096202956
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25135,93,0.55 [0.32-0.95],0.030887640522701
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other headache syndromes,25605,75,0.92 [0.53-1.59],0.7658077550454834
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other neurological diseases,27160,505,1.05 [0.86-1.29],0.6241078826344832
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Other sleep disorders,25932,402,1.09 [0.87-1.36],0.4663881441230203
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Parkinson's disease,27256,312,1.03 [0.79-1.35],0.8056296713451292
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,26737,82,0.69 [0.40-1.20],0.1884061973182042
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Restless leg syndrome,27278,100,1.16 [0.75-1.81],0.5038732754139645
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Sleep apnoea,27103,318,1.09 [0.84-1.40],0.5174965114318252
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27027,40,0.98 [0.46-2.08],0.9620704098258954
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27269,150,1.04 [0.71-1.52],0.831403527484301
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25108,66,0.79 [0.43-1.46],0.4606206306123545
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27280,362,1.00 [0.78-1.28],0.9972634244029448
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),26729,97,1.06 [0.66-1.71],0.8141659645090858
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,26699,108,0.75 [0.46-1.22],0.2396908991465365
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,26814,477,0.67 [0.53-0.85],0.0009025514808587
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27132,170,0.85 [0.59-1.24],0.4017392451939996
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26171,62,0.90 [0.49-1.66],0.745348104358907
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26162,53,0.64 [0.32-1.29],0.2108636594201158
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27159,58,0.95 [0.51-1.77],0.8615408695255451
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,26990,164,0.77 [0.52-1.14],0.1936954822723264
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1692,39,0.83 [0.38-1.79],0.6298422178237422
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2034,71,0.63 [0.35-1.13],0.1210847610231486
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,26680,89,1.19 [0.75-1.89],0.4590777339799692
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27096,1045,1.04 [0.90-1.20],0.6367100840706881
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26860,751,0.85 [0.71-1.01],0.0666911265376745
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26399,290,1.06 [0.81-1.39],0.6673256427232421
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27185,848,0.83 [0.70-0.99],0.0354978829928938
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27262,69,1.40 [0.86-2.26],0.1747506903777067
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27111,774,0.81 [0.68-0.97],0.019573132004207
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27233,407,0.97 [0.77-1.23],0.7985955326293929
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27189,200,0.75 [0.52-1.06],0.1066017491922323
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26149,40,0.88 [0.41-1.87],0.7372613029781073
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26155,46,0.70 [0.34-1.48],0.3553949281711873
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26170,61,0.66 [0.35-1.28],0.2211410012824793
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27187,716,1.03 [0.87-1.23],0.7311776328246589
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,26650,179,1.00 [0.71-1.43],0.9800806649035074
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,26402,65,1.44 [0.87-2.36],0.152835507936751
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,26927,101,1.07 [0.68-1.70],0.761864460089536
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27138,312,0.91 [0.69-1.20],0.4920809467096945
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,26550,213,0.92 [0.67-1.28],0.6382144189993899
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27117,128,0.77 [0.49-1.19],0.2351690779087583
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26942,471,1.07 [0.86-1.32],0.5465867564876614
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,26745,154,1.39 [1.01-1.92],0.0462248338019161
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,25497,2509,1.01 [0.92-1.11],0.7930374603092554
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27097,271,0.88 [0.66-1.19],0.4108220298158338
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27256,153,1.01 [0.69-1.47],0.9782272627150737
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26501,392,0.85 [0.67-1.09],0.201623385168558
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,26889,63,1.17 [0.66-2.06],0.5924237274900397
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27247,54,1.43 [0.83-2.45],0.1975051270944423
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26202,93,1.00 [0.61-1.62],0.9921637016544468
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26266,157,0.76 [0.51-1.13],0.1786518781376273
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26161,110,0.95 [0.60-1.50],0.8120785020381249
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,26407,70,1.03 [0.59-1.78],0.9264540788883656
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26110,59,0.84 [0.44-1.59],0.5862795619736557
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,26589,118,0.75 [0.47-1.20],0.2269666785856518
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",26647,176,1.17 [0.83-1.65],0.3690076229082273
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26244,135,0.99 [0.66-1.48],0.9668377574914184
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26150,99,1.12 [0.71-1.75],0.6307949463865092
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26127,76,0.63 [0.35-1.14],0.127143014763514
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25077,2089,0.94 [0.85-1.04],0.2554301115851173
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26190,81,1.04 [0.62-1.74],0.8789547978734413
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27018,427,1.14 [0.92-1.42],0.232796388267333
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,26637,46,1.26 [0.67-2.40],0.4749125598943309
CEBPB,CCAAT/enhancer-binding protein beta,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),26751,160,0.98 [0.68-1.42],0.9199393780208132
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27041,117,0.92 [0.59-1.43],0.7126636502962987
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27234,117,0.90 [0.58-1.41],0.6414952566395475
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27153,142,0.74 [0.49-1.12],0.1533383831366382
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,26993,69,0.99 [0.56-1.75],0.971789816631758
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,26991,67,0.89 [0.50-1.59],0.691072640490731
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27175,807,0.94 [0.80-1.12],0.4989682083916081
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,26923,555,0.98 [0.80-1.20],0.865200381707775
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,26490,122,0.97 [0.63-1.49],0.8921158745108022
CEBPB,CCAAT/enhancer-binding protein beta,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,26448,80,0.87 [0.51-1.48],0.6014125523598092
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute pharyngitis,27007,86,0.67 [0.39-1.15],0.1489005018576582
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27154,233,0.67 [0.48-0.93],0.0159895433869135
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,26983,62,0.83 [0.45-1.54],0.5620220094589506
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,All influenza,25569,129,1.38 [0.97-1.97],0.0776116161945698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),25567,127,1.37 [0.95-1.96],0.0905369163941463
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19371,127,0.79 [0.51-1.22],0.284345522866794
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Allergic rhinitis,27124,285,0.96 [0.73-1.27],0.7675729900948167
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21107,2052,0.99 [0.89-1.10],0.8551360216568353
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21272,2028,1.00 [0.90-1.11],0.9980003298367514
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),26861,123,1.52 [1.08-2.14],0.0164092470814908
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",25506,66,1.85 [1.27-2.70],0.0014861579367781
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Bronchiectasis,23590,407,1.19 [0.96-1.48],0.120669042896468
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23254,71,1.13 [0.67-1.92],0.6391187634025233
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26129,2946,0.99 [0.91-1.08],0.8678402359003641
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26003,61,1.20 [0.69-2.08],0.5218595484943414
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Chronic sinusitis,26087,145,1.38 [0.99-1.92],0.054648225887229
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27105,1051,1.04 [0.91-1.20],0.5482157080831886
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Deviated nasal septum,26013,71,0.58 [0.32-1.07],0.0821715484643031
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25205,5139,1.02 [0.95-1.08],0.6276315990654755
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26275,333,0.91 [0.70-1.18],0.4807584318019481
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Early onset COPD,26367,313,0.99 [0.77-1.29],0.9565016576659712
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Emphysema,23452,269,1.06 [0.81-1.38],0.6900378955056718
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25654,227,1.31 [1.00-1.73],0.0519288963903256
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27086,1646,1.12 [1.00-1.25],0.0502646522067255
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Interstitial lung disease,25693,266,1.23 [0.95-1.60],0.1191386075020356
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Later onset COPD,26363,738,1.05 [0.89-1.24],0.5636793295940876
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27272,226,0.93 [0.67-1.28],0.6458149319473333
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Nasal polyp,26007,65,0.75 [0.41-1.40],0.3696461876148279
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27053,919,1.07 [0.92-1.25],0.3556905230141836
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of pleura,27095,1750,1.13 [1.02-1.26],0.0237812226385027
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26728,786,1.05 [0.89-1.23],0.5841558953131223
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other pleural conditions,25382,37,1.75 [1.04-2.96],0.0354074611646022
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27196,342,1.28 [1.02-1.61],0.0348640489599442
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27192,1184,1.13 [0.99-1.29],0.0639227036236036
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural effusion,26190,845,1.17 [1.01-1.36],0.0408804382443899
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pleural plaque,25391,46,0.97 [0.49-1.95],0.9417827932951256
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26851,1411,1.12 [0.99-1.26],0.0660359116789162
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27242,196,0.97 [0.69-1.36],0.8585327891383134
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pneumothorax,25436,91,1.12 [0.70-1.78],0.6429268348225166
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pollen allergy,27248,238,1.01 [0.75-1.36],0.959357175585792
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Pulmonary oedema,26918,64,1.70 [1.09-2.65],0.020443597396446
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19296,52,0.46 [0.22-0.94],0.0320464823447081
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27028,894,1.10 [0.94-1.27],0.2368454926211838
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26227,285,0.96 [0.72-1.26],0.7581436875051429
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Viral pneumonia,25655,215,0.95 [0.69-1.30],0.7398468086859414
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",26874,171,0.98 [0.69-1.40],0.9061650909106288
CEBPB,CCAAT/enhancer-binding protein beta,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13163,109,1.28 [0.85-1.92],0.2311213082478776
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19452,38,0.92 [0.43-1.99],0.8338728801610137
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute appendicitis,27096,145,0.81 [0.54-1.21],0.2978500264243671
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute gastritis,20465,91,1.12 [0.70-1.80],0.6332179277364454
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute pancreatitis,24992,163,0.91 [0.63-1.33],0.6244563723112522
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Acute peritonitis,26710,85,1.22 [0.77-1.95],0.3955743579755936
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26403,32,0.73 [0.31-1.76],0.4874615819355218
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Barrett oesophagus,20713,339,0.80 [0.62-1.05],0.109824931376729
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",24910,81,1.61 [1.07-2.43],0.0236184902215224
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",26857,81,1.59 [1.06-2.40],0.0267208374915368
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholecystitis,25016,187,1.47 [1.10-1.95],0.0087355047311087
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Cholelithiasis,26006,1177,0.92 [0.80-1.06],0.2596733559273953
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic gastritis,20717,343,0.96 [0.75-1.24],0.7770059732780286
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Chronic pancreatitis,24871,42,0.39 [0.17-0.88],0.0235285031254875
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27198,72,0.78 [0.44-1.39],0.4043123532661145
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Coeliac disease,25721,149,0.81 [0.54-1.22],0.306368890756347
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Collagenous colitis,25389,111,0.85 [0.53-1.34],0.4791051910401774
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27142,150,1.00 [0.68-1.46],0.994044414610886
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Constipation,26933,1715,0.89 [0.79-1.00],0.05242381997496
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn disease,25372,94,0.82 [0.49-1.35],0.4332104836613687
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26926,70,0.81 [0.45-1.45],0.4681511087271608
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25375,97,0.84 [0.52-1.38],0.4962618638085412
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Dental caries,26468,229,1.05 [0.78-1.42],0.7547559283213762
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25659,2465,0.95 [0.86-1.04],0.2573401498332144
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of appendix,27138,187,0.86 [0.60-1.22],0.3859723712954507
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of liver,27178,807,1.10 [0.94-1.29],0.2505911683365789
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24977,4603,0.93 [0.87-1.00],0.0496014118197358
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26816,577,0.99 [0.82-1.20],0.916558278403332
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27158,533,1.04 [0.85-1.27],0.7036307549613164
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26354,115,0.77 [0.49-1.22],0.265150383792888
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26204,64,0.92 [0.51-1.66],0.7896105390970743
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26973,1401,1.04 [0.92-1.18],0.512054193260322
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diseases of tongue,26216,110,0.90 [0.57-1.42],0.6502984807759404
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26410,1581,0.97 [0.86-1.09],0.5964608640963429
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22617,3203,0.97 [0.90-1.06],0.5476515296640365
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Duodenal ulcer,20503,129,0.80 [0.52-1.24],0.3249037816832962
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27227,108,0.67 [0.41-1.08],0.1009211475687616
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27181,61,1.55 [0.98-2.47],0.0623772355973176
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26463,92,0.83 [0.50-1.37],0.4674493419052966
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19525,111,1.14 [0.75-1.74],0.5459755014080581
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Functional dyspepsia,21032,658,0.84 [0.69-1.02],0.0711141259936644
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastric ulcer,20724,350,1.00 [0.78-1.28],0.976860483260526
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23152,2778,0.89 [0.81-0.97],0.0106746913683589
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20846,472,0.97 [0.78-1.21],0.794563128738198
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21344,8410,0.98 [0.93-1.03],0.512725487950158
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,GI-bleeding,26705,1133,1.04 [0.91-1.20],0.5491688995219537
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26302,63,0.69 [0.37-1.30],0.2533483430276046
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20380,1258,0.93 [0.82-1.07],0.3230549653619146
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26411,40,0.80 [0.37-1.74],0.5753336003362441
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Hernia,26095,2901,0.96 [0.88-1.05],0.3811434190374145
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impacted teeth,27191,56,1.68 [1.07-2.64],0.0244493192510044
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Impaction of intestines,19478,64,1.80 [1.18-2.74],0.0064107501712586
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Inguinal hernia,23354,160,1.30 [0.94-1.81],0.1128040142202433
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19514,100,0.76 [0.46-1.25],0.2755999892563236
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25748,176,0.85 [0.59-1.23],0.3983709387236775
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20231,817,0.86 [0.73-1.02],0.0931173113601751
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27263,358,1.23 [0.98-1.55],0.0718064206573902
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26095,817,0.98 [0.83-1.16],0.8149158355076982
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26377,1099,0.89 [0.77-1.03],0.1261026842882505
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20533,159,0.67 [0.45-1.00],0.048493102090505
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oesophagitis,20945,571,0.76 [0.62-0.94],0.009574099360511
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27232,157,1.21 [0.86-1.70],0.2660170558416276
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23253,59,0.82 [0.43-1.55],0.5350358045851922
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20682,1268,0.95 [0.83-1.08],0.4182846051560362
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25129,300,1.05 [0.81-1.37],0.7099652555884657
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25014,185,0.86 [0.60-1.23],0.4165838204904512
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestine,20998,1584,0.98 [0.87-1.10],0.7508583964603179
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of intestines,25129,5715,0.98 [0.92-1.04],0.4700545364130644
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26207,233,1.12 [0.83-1.49],0.4589940159735454
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of liver,27052,681,1.12 [0.95-1.33],0.1785524467421793
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20953,579,0.80 [0.65-0.98],0.0334407309926901
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of pancreas,24987,158,0.76 [0.51-1.13],0.1742102109043495
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27096,471,1.00 [0.80-1.23],0.9658621191882328
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21455,1081,0.83 [0.71-0.96],0.0143474883654299
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26723,1151,1.06 [0.92-1.21],0.4372188400747866
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26426,187,0.85 [0.60-1.21],0.3636948351557569
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21180,1766,0.88 [0.78-0.98],0.0255424181442154
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22485,2111,0.97 [0.88-1.08],0.5669509292563257
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26468,97,0.85 [0.52-1.38],0.5055634143373905
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26243,965,0.91 [0.78-1.06],0.2065393702674378
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19743,329,1.17 [0.92-1.49],0.2023599465534009
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27170,69,1.34 [0.82-2.18],0.2388364297800318
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19905,491,0.98 [0.80-1.22],0.8790631018223986
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25701,129,1.12 [0.76-1.67],0.5604250254671785
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27271,69,1.21 [0.72-2.03],0.4700244668945308
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26242,127,1.03 [0.68-1.54],0.8995776086642326
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Toxic colitis,25345,67,0.36 [0.19-0.69],0.0020178336071703
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20600,226,0.79 [0.57-1.09],0.1491328877118337
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ulcerative colitis,25445,167,0.84 [0.58-1.23],0.3791026398256246
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25414,136,0.93 [0.62-1.40],0.7411149147066179
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Umbilical hernia,23369,175,1.04 [0.73-1.46],0.8405001084288121
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,19600,186,0.75 [0.52-1.09],0.130221406490305
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Ventral hernia,23452,258,1.13 [0.85-1.49],0.3998179570016226
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XI Diseases of the digestive system,Volvulus,19501,87,0.51 [0.29-0.90],0.0190863694578564
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27191,258,0.89 [0.66-1.21],0.4664232657741014
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,26957,78,1.15 [0.70-1.90],0.5784548775038418
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25223,213,0.83 [0.60-1.17],0.2904084015432084
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26753,626,1.15 [0.96-1.37],0.1283786496565123
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26270,143,1.18 [0.82-1.70],0.3818767551813713
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25348,338,0.86 [0.66-1.12],0.2654546378534672
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,26971,279,1.14 [0.87-1.49],0.3293761799148968
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27172,480,1.09 [0.89-1.34],0.3946126992709663
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,26742,50,1.20 [0.64-2.22],0.5699044859069196
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25682,3154,0.96 [0.89-1.05],0.3892733274008918
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26828,477,1.08 [0.88-1.33],0.4580905631144146
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26682,331,0.97 [0.75-1.26],0.8230377772367145
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26965,838,1.20 [1.03-1.40],0.0162843406021455
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27256,78,0.87 [0.50-1.51],0.6188089031437607
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25100,90,0.69 [0.41-1.17],0.1687707417956188
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26396,45,1.44 [0.80-2.59],0.2218493468058393
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,26957,265,1.11 [0.84-1.46],0.4741006888979672
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25419,409,0.78 [0.61-1.00],0.047939251155771
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25057,47,1.07 [0.55-2.08],0.8409024006527543
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27176,83,0.84 [0.49-1.44],0.5203315272676139
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26287,160,1.23 [0.87-1.74],0.2326352263928457
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27047,168,1.00 [0.69-1.43],0.982122889002813
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,26747,55,1.27 [0.71-2.29],0.4229135594956608
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25074,64,0.72 [0.38-1.37],0.3197971459512267
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26588,1578,0.86 [0.76-0.97],0.0141282931355053
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25454,444,0.79 [0.63-1.00],0.0493588451132021
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25062,52,1.09 [0.58-2.03],0.7950634829752021
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27193,314,0.97 [0.75-1.27],0.8488701522784716
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,26774,82,0.84 [0.49-1.44],0.5348706040824498
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27119,240,1.01 [0.75-1.37],0.92652068953521
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27227,294,0.83 [0.62-1.11],0.2024486581555571
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25164,154,0.72 [0.48-1.08],0.1127177713637108
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25270,260,0.88 [0.65-1.19],0.3921792661897894
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27212,279,0.83 [0.62-1.12],0.2197645198806895
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25208,198,1.16 [0.84-1.59],0.3690027388349
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27243,150,0.95 [0.64-1.40],0.7806534410340954
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23264,126,0.84 [0.55-1.30],0.4393479932331066
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,24770,6355,0.92 [0.86-0.97],0.0046361619056769
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23388,4973,0.91 [0.85-0.97],0.0068589534574151
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23217,79,1.39 [0.88-2.19],0.1557090356493273
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23381,152,1.22 [0.85-1.74],0.2778629764804363
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23437,208,1.10 [0.80-1.51],0.5726414488204317
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,26993,115,0.96 [0.62-1.48],0.8530082648876245
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23349,120,0.90 [0.58-1.40],0.643445235443391
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19771,1356,0.95 [0.83-1.08],0.4417556076623898
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27126,220,1.17 [0.87-1.58],0.3033842869451835
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23837,608,0.97 [0.80-1.17],0.7471743026333239
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,22915,8084,0.92 [0.87-0.97],0.0027865793917199
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24426,134,0.92 [0.61-1.39],0.7031559293261698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23270,132,0.79 [0.52-1.22],0.2892800196002884
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23825,687,1.05 [0.88-1.25],0.6095644495053705
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26260,3031,0.96 [0.88-1.05],0.3878945914383419
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23313,175,0.73 [0.50-1.07],0.1061812272993212
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,23516,378,0.77 [0.60-0.99],0.043268672263184
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23310,172,1.08 [0.76-1.52],0.6643441449699985
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26333,104,1.01 [0.64-1.59],0.966569666821891
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20300,1885,0.88 [0.78-0.98],0.0230725959152997
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18638,223,1.20 [0.88-1.64],0.2433965702790881
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27265,220,1.25 [0.93-1.68],0.1356224020485911
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18514,99,0.93 [0.57-1.50],0.7557701664806145
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18980,565,0.89 [0.72-1.09],0.2457602975736863
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23473,335,0.91 [0.70-1.19],0.4966410024067911
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19051,636,0.85 [0.70-1.03],0.0969190098604217
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23297,68,0.94 [0.52-1.68],0.8334538173436599
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23950,721,1.03 [0.86-1.22],0.7703972656863386
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23566,337,1.13 [0.88-1.44],0.3380868679039351
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19011,596,0.83 [0.68-1.01],0.0660175270360017
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23229,91,0.96 [0.58-1.58],0.861643488803208
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23208,70,0.68 [0.37-1.25],0.2172112348034693
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24344,52,1.22 [0.67-2.21],0.5125380426257033
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26799,2507,0.87 [0.79-0.96],0.0048899623419646
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26096,1804,0.84 [0.75-0.94],0.0027657827223837
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27081,599,1.12 [0.93-1.34],0.241611948743505
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21440,3025,0.91 [0.83-0.99],0.0378502104274993
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18488,73,0.95 [0.55-1.66],0.8637787928434119
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23239,101,1.09 [0.70-1.71],0.7052726251720322
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18457,42,1.18 [0.59-2.39],0.6395920258829698
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18613,198,0.69 [0.48-0.98],0.0406348057728568
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24581,289,0.90 [0.68-1.19],0.4526068909510532
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,24878,586,0.92 [0.76-1.12],0.4071935481705533
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27249,111,1.01 [0.65-1.57],0.968817303123332
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25275,2046,0.98 [0.88-1.08],0.6654180413159484
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23270,132,1.15 [0.78-1.69],0.4754106531003232
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18640,225,0.63 [0.45-0.88],0.0077955503635203
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24040,811,0.98 [0.83-1.15],0.7713268886747169
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20956,2541,0.89 [0.81-0.98],0.0143322653980084
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26357,128,1.18 [0.80-1.74],0.3997025453450485
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27259,77,1.19 [0.73-1.95],0.4867318512423103
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23221,83,0.84 [0.49-1.43],0.5116877971946641
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24614,1476,0.89 [0.79-1.01],0.0783308562973232
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23219,81,1.00 [0.59-1.69],0.9910896609072184
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20412,1997,0.95 [0.85-1.05],0.3071531133011391
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24425,133,0.82 [0.54-1.25],0.3562401187209307
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23201,63,1.32 [0.79-2.19],0.2862262171555275
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,23427,198,0.62 [0.43-0.89],0.0095757419371049
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23729,591,0.95 [0.78-1.16],0.6105108416621963
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26732,503,1.07 [0.87-1.31],0.5253888614947018
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23879,650,1.00 [0.83-1.20],0.983378925896732
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27094,578,1.14 [0.94-1.37],0.1770639978127627
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27250,67,1.24 [0.73-2.08],0.4235173181862648
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23363,225,1.06 [0.78-1.44],0.688140439242109
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20923,925,1.02 [0.87-1.19],0.7901073995445738
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23805,667,1.01 [0.84-1.21],0.897636827381757
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23263,125,0.72 [0.46-1.14],0.1599446880997595
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18492,77,0.92 [0.53-1.60],0.778721796962623
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21055,2640,0.96 [0.88-1.06],0.4415826123620466
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19250,835,0.90 [0.76-1.06],0.2115904672076503
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,26527,298,1.19 [0.92-1.54],0.1935425537009324
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27222,84,0.97 [0.58-1.63],0.906509430815109
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",24967,51,1.07 [0.57-2.02],0.8355703942397048
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18493,78,1.15 [0.69-1.90],0.5869166915541391
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23342,113,0.88 [0.56-1.38],0.5750638951329831
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19017,602,1.09 [0.90-1.31],0.3704433384324143
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23472,334,0.81 [0.62-1.06],0.1222609366603372
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23518,289,0.90 [0.68-1.20],0.4890143928001385
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,23510,281,0.86 [0.64-1.15],0.2950384839993104
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21052,86,1.41 [0.93-2.15],0.1039809960974347
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27257,74,1.24 [0.75-2.03],0.4004437438726661
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23780,642,0.92 [0.77-1.11],0.4049963695863514
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],26386,157,0.85 [0.57-1.25],0.3997734547184998
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25951,2813,0.91 [0.83-1.00],0.0505627603871117
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23293,155,0.79 [0.53-1.18],0.2475986421878691
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23798,569,0.97 [0.79-1.18],0.7324828865316697
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,25567,263,0.80 [0.59-1.08],0.1489459623121157
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,23507,278,1.12 [0.86-1.47],0.3968934856082012
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24988,1759,0.97 [0.86-1.08],0.5415048687805422
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24427,1198,1.03 [0.90-1.17],0.7092191416602165
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23202,64,1.28 [0.75-2.16],0.3654164702838248
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26450,221,0.73 [0.52-1.02],0.0614900069112822
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23338,200,1.06 [0.76-1.47],0.7335937667223615
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23265,127,0.83 [0.54-1.29],0.4120300231866317
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18471,56,1.09 [0.58-2.03],0.7854301028111751
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26202,1255,1.12 [0.99-1.28],0.078733174511128
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20389,100,1.05 [0.67-1.66],0.8230161202375641
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26575,110,0.91 [0.58-1.43],0.6717895193494732
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27117,235,0.94 [0.69-1.28],0.7169046992895113
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,26909,27,0.91 [0.36-2.29],0.8370745403940116
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26437,1490,1.19 [1.06-1.34],0.0025443456997599
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27103,79,0.89 [0.52-1.53],0.6663042455914212
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27070,242,1.00 [0.74-1.35],0.9881351641052336
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Cystitis,24073,251,0.83 [0.61-1.13],0.2451852873625789
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Dialysis,25002,55,1.99 [1.35-2.93],0.0005545785346069
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26806,341,0.86 [0.66-1.11],0.2432795707430325
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Endometriosis,20468,179,0.90 [0.63-1.28],0.5440464279640729
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20690,401,0.81 [0.63-1.03],0.0816066498242221
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21291,1002,0.89 [0.76-1.04],0.1305045872491217
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21221,5050,1.00 [0.94-1.07],0.9985851313725768
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27089,65,1.09 [0.62-1.91],0.7632613892299683
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,24826,211,1.00 [0.73-1.38],0.9902332819423796
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26731,405,0.82 [0.64-1.04],0.1052953672810721
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Irregular menses,26811,128,0.56 [0.36-0.88],0.0120322558796492
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20598,309,0.83 [0.63-1.09],0.1693798698888531
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23897,75,1.25 [0.77-2.04],0.3677827485006726
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22750,2461,0.93 [0.85-1.03],0.1577387603705948
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20433,144,0.80 [0.53-1.20],0.2755591444772377
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27264,62,0.57 [0.30-1.10],0.0944110472331331
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27268,77,0.93 [0.54-1.60],0.7883254262220509
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26045,2223,1.02 [0.93-1.13],0.6284516291006204
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24289,467,0.88 [0.70-1.10],0.2538833677133575
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26584,119,0.65 [0.41-1.04],0.0701791037827455
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27218,390,1.02 [0.81-1.29],0.8586684945067926
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27219,93,1.08 [0.67-1.73],0.7540045922480543
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25730,1908,1.03 [0.93-1.15],0.5508786922401916
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26537,211,0.84 [0.61-1.18],0.3153633109465529
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20439,150,0.86 [0.58-1.28],0.4620404342893003
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20659,370,0.79 [0.61-1.01],0.0629909060106738
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20401,112,0.90 [0.57-1.41],0.6363519898552599
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20492,203,0.81 [0.58-1.14],0.2359351652308583
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24878,263,1.04 [0.78-1.38],0.7889873542591279
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,26955,127,0.99 [0.65-1.49],0.9556438972473608
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20601,312,0.89 [0.68-1.16],0.390888500850553
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20397,108,0.92 [0.58-1.44],0.7066325181790214
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20940,651,1.02 [0.86-1.23],0.7928046780765061
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20452,163,0.90 [0.62-1.31],0.5811849098557115
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20878,589,1.02 [0.85-1.24],0.8074426311854327
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27060,36,1.88 [1.16-3.03],0.0100619167481575
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27082,2467,1.12 [1.02-1.23],0.0131496969210487
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",24779,164,1.02 [0.71-1.47],0.8993276258338285
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25050,103,1.24 [0.81-1.89],0.3322525100870013
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26917,35,0.99 [0.45-2.16],0.9701681820351944
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23966,144,1.01 [0.68-1.50],0.9693135398145664
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27151,269,0.96 [0.72-1.27],0.7572522948073616
CEBPB,CCAAT/enhancer-binding protein beta,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20432,143,1.32 [0.93-1.87],0.1154818223995325
